Diamond Hill Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $984K | Buy |
116,203
+46,104
| +66% | +$391K | ﹤0.01% | 174 |
|
|
2025
Q1 | $564K | Hold |
70,099
| – | – | ﹤0.01% | 172 |
|
|
2024
Q4 | $629K | Hold |
70,099
| – | – | ﹤0.01% | 174 |
|
|
2024
Q3 | $514K | Hold |
70,099
| – | – | ﹤0.01% | 170 |
|
|
2024
Q2 | $400K | Hold |
70,099
| – | – | ﹤0.01% | 168 |
|
|
2024
Q1 | $351K | Buy |
70,099
+15,020
| +27% | +$75.3K | ﹤0.01% | 162 |
|
|
2023
Q4 | $495K | Buy |
55,079
+26,505
| +93% | +$238K | ﹤0.01% | 155 |
|
|
2023
Q3 | $222K | Hold |
28,574
| – | – | ﹤0.01% | 164 |
|
|
2023
Q2 | $277K | Hold |
28,574
| – | – | ﹤0.01% | 162 |
|
|
2023
Q1 | $313K | Hold |
28,574
| – | – | ﹤0.01% | 161 |
|
|
2022
Q4 | $123K | Hold |
28,574
| – | – | ﹤0.01% | 169 |
|
|
2022
Q3 | $215K | Hold |
28,574
| – | – | ﹤0.01% | 167 |
|
|
2022
Q2 | $287K | Hold |
28,574
| – | – | ﹤0.01% | 161 |
|
|
2022
Q1 | $354K | Buy |
28,574
+9,390
| +49% | +$116K | ﹤0.01% | 161 |
|
|
2021
Q4 | $439K | Buy |
19,184
+715
| +4% | +$16.4K | ﹤0.01% | 158 |
|
|
2021
Q3 | $409K | Hold |
18,469
| – | – | ﹤0.01% | 155 |
|
|
2021
Q2 | $239K | Buy |
+18,469
| New | +$239K | ﹤0.01% | 153 |
|